In premarket trading, several companies exhibited notable movements in their stock prices. Revvity saw a 7% increase in shares following an upward revision of its full-year pro forma adjusted earnings per share guidance, which now stands between $5.40 and $5.45, up from a prior estimate of $5.30 to $5.40.
Pfizer’s shares remained mostly unchanged after the pharmaceutical giant released its third-quarter results, reporting earnings of 87 cents per share on revenues of $16.58 billion, surpassing analyst expectations of 73 cents earnings per share and $15.87 billion in revenue.
Conversely, Zebra Technologies experienced a decline of over 6% despite beating third-quarter estimates with earnings of $4.95 per share on revenues of $1.61 billion. Analysts had predicted earnings of $4.89 per share on revenues of $1.57 billion, but the company’s free cash flow guidance fell short, projected at $1 billion compared to an expectation of $1.02 billion.
Similarly, Gartner’s shares decreased by more than 6%, even with results that surpassed expectations and a positive earnings outlook for the year. Yum Brands saw a modest rise of 1% following a strong performance in its third-quarter earnings, which came in at $1.56 per share, exceeding the forecast of $1.49.
Palantir Technologies saw its shares drop nearly 8% despite reporting solid earnings that exceeded Wall Street expectations, with a 148% increase in U.S. commercial revenue. Lastly, Apple’s stock fell almost 4% due to a disappointing forecast for margins and lower-than-expected iPad sales in the last fiscal quarter.
Why this story matters
- The performance of these companies can indicate broader economic trends in various sectors.
Key takeaway
- Earnings reports significantly influence stock movements, with companies exceeding expectations sometimes seeing declines due to other factors.
Opposing viewpoint
- While some companies faced declines despite strong earnings, their long-term prospects remain optimistic, highlighting the volatility of market reactions.
